CD70-specific CAR-NK cells demonstrated potent cytolytic activity against CD70+ MM cell lines, while showing the same cytotoxicity toward the CD70− H929 myeloma line as non-engineered NK cells, confirming their antigen specificity. This evidence concerns the gene CD70 and Miyoshi myopathy.